GlassScriptPhysician profile
Andrew G Hune
NPI 1720341787
$2,596.18
in general payments reported to CMS, 2019-2025
17 companies · $991 in 2025
The $991 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $248 · 2020: $97.62 · 2021: $15.81 · 2022: $137 · 2023: $232 · 2024: $875 · 2025: $991.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,098.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,097.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $402.81 | 2024-2025 | Krystexxa |
| Stryker Corporation | $340.20 | 2019-2024 | Phalinx, Ortholoc 2 Lapifuse, Easyfuse |
| Treace Medical Concepts, INC. | $279.32 | 2023-2025 | |
| Paratek Pharmaceuticals, INC. | $224.74 | 2024-2025 | Nuzyra |
| Smith+Nephew, INC. | $213.91 | 2022-2024 | Grafix Pl |
| Kerecis Limited | $181.33 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Bioventus LLC | $158.75 | 2020-2025 | Exogen Ultrasound Bone Healing System |
| Trilliant Surgical LLC. | $150.00 | 2025 | Arsenal Ankle |
| Next Science LLC | $138.99 | 2024 | Surgx, Blastx, Xperience |
| Advanced Oxygen Therapy INC. | $129.06 | 2022-2025 | Topical Oxygen Chamber For Extremities |
| Organogenesis INC. | $123.02 | 2020-2024 | Puraply |
| Melinta Therapeutics, LLC | $113.14 | 2019 | |
| Dynasplint Systems INC. | $41.04 | 2023 | Dynasplint |
| Wright Medical Technology, INC. | $36.72 | 2020 | |
| Grt US Holding, INC. | $28.77 | 2020-2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Averitas Pharma INC. | $22.40 | 2024 | Qutenza |
| Merck Sharp & Dohme LLC | $11.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Hune listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.